banner
Eltrombopag, Purity ≥98%
Inquiry

Cat. No.: X24-09-YM1169

Eltrombopag, Purity ≥98%

Synonym: 496775-61-2; SB 497115; SB497115; SB-497115; 3-[3-[[2-(3,4-Dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acid

  • MDL: MFCD20926253
  • CAS Number: 496775-61-2
  • Compound CID: 135449332
img
Product Size
10 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
Eltrombopag, soluble in DMSO and insoluble in water and ethanol, is an agonist of the thrombopoietin (TPO) receptor. The molecular weight of the compound is 442.47, and its molecular formula is C25H22N4O4.
Molecular Weight
442.47
Molecular Formula
C25H22N4O4
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Solubility
In vitro: DMSO (warmed): 22 mg/mL (49.72 mM); Water: insoluble; Ethanol: insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
Eltrombopag plays a key role in enhancing signaling pathways that stimulate megakaryocyte proliferation and differentiation.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0